Abbott Laboratories Analyst Price Targets - Benzinga

Abbott Laboratories

ABTNYSE

Trade with Public

Trade with Public

$104.39

-0.29-0.28%

Dern. MÀJ: Oct 16, 12:29 PM

$105.84

1.161.11%

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Abbott Laboratories Analyst Price Targets - Benzinga

Abbott Laboratories Analyst Price Targets

Wall Street analyst price targets and consensus rating for Abbott Laboratories (ABT).

Price Target Range — 9 Quarters

Analyst Consensus — 23 Analysts

22Buy

1Hold

Consensus RatingBuy# Analysts23Avg. Consensus PT$129Upside to Avg. PT+23.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 16, 2026	TD Cowen	Joshua Jennings	Maintained	Buy	$135
Oct 7, 2026	Barclays	Matt Miksic	Initiate	Overweight	$120
Oct 2, 2026	Rothschild & Co	Ed Ridley-Day	Upgrade	Neutral→Buy	$119→$127
Sep 8, 2026	TD Cowen	Joshua Jennings	Maintained	Buy	$135
Aug 21, 2026	TD Cowen	Joshua Jennings	PT Raise	Buy	$115→$135
Aug 14, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$112→$125
Aug 13, 2026	Wolfe Research	Mike Polark	Upgrade	Peer Perform→Outperform	$130
Jul 28, 2026	UBS	Patrick Wood	PT Cut	Buy	$135→$125
Jul 17, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$108→$112
Jul 17, 2026	Piper Sandler	Adam Maeder	PT Raise	Overweight	$115→$118
Jul 17, 2026	JP Morgan	Robbie Marcus	PT Raise	Overweight	$110→$120
Jul 17, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$109→$112
Jul 17, 2026	TD Cowen	Joshua Jennings	Maintained	Buy	$115
Jul 17, 2026	Evercore ISI Group	Vijay Kumar	PT Raise	Outperform	$112→$120
Jul 17, 2026	RBC Capital	Shagun Singh	Maintained	Outperform	$130
Jul 17, 2026	BTIG	Marie Thibault	PT Raise	Buy	$131→$134
Jul 6, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$120→$112
Jul 1, 2026	Baird	David Rescott	Initiate	Outperform	$121
Jun 22, 2026	Piper Sandler	Adam Maeder	Maintained	Overweight	$115
May 31, 2026	Goldman Sachs	David Roman	PT Cut	Buy	$121→$113

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $135 Price Target

TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintains $135 price target.

Benzinga Newsdesk

This Generac Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Overweight GNRC ($303), Buy ENTG ($200) and VYLR ($87), Neutral SPOT ($540).

Avi Kapoor

Eli Lilly To Rally Over 21%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts raised targets for Everpure, Eli Lilly and Delek US, while cutting targets for Constellation, Tyler, ArriVent and Netflix.

Avi Kapoor

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated coverage: Neutral on Honeywell Aerospace; Outperform on M&T Bank and SailPoint; Buy on Ambiq Micro; Overweight on Abbott.

Avi Kapoor

Micron To Rally Around 187%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts revised targets: upgrades for NetApp and Humana; downgrades for PJT Partners; mixed target changes for Redwood, Marvell, Yum and S&P

Avi Kapoor

PRO
Barclays Initiates Coverage On Abbott Laboratories with Overweight Rating, Announces Price Target of $120

Barclays analyst Matt Miksic initiates coverage on Abbott Laboratories (NYSE:ABT) with a Overweight rating and announces Price Target of $120.

Benzinga Newsdesk